1,026 results on '"Scotlandi, Katia"'
Search Results
2. Extracellular vesicle-associated IGF2BP3 tunes Ewing sarcoma cell migration and affects PI3K/Akt pathway in neighboring cells
3. EHD1-dependent traffic of IGF-1 receptor to the cell surface is essential for Ewing sarcoma tumorigenesis and metastasis
4. Profilin 1 deficiency drives mitotic defects and reduces genome stability
5. ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis
6. A global collaboRAtive study of CIC-rearranged, BCOR::CCNB3-rearranged and other ultra-rare unclassified undifferentiated small round cell sarcomas (GRACefUl)
7. Extracellular Interactors of the IGF System: Impact on Cancer Hallmarks and Therapeutic Approaches
8. Payload-delivering engineered γδ T cells display enhanced cytotoxicity, persistence, and efficacy in preclinical models of osteosarcoma
9. Does PAX7 and NKX2.2 immunoreactivity in Ewing sarcoma have prognostic significance?
10. miR-486-5p expression is regulated by DNA methylation in osteosarcoma
11. Correction: Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cells
12. Phospholipase Cδ-4 (PLCδ4) Acts as a Nuclear Player to Influence Cyclin B Expression in the Embryonal Rhabdomyosarcoma Cell Lines RD and A204.
13. CCN proteins in the musculoskeletal system: current understanding and challenges in physiology and pathology
14. Supplementary Figure 5 from Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages
15. Supplementary Figure 3 from Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages
16. Data from Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages
17. Supplementary video 1 from Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages
18. Supplementary Figure 9 from Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages
19. Supplementary Figure 11 from Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages
20. Supplementary Figure 4 from Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages
21. Supplementary Figure 2 from Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages
22. Supplementary Table S1 from Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages
23. Supplementary video 2 from Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages
24. Supplementary Figure 7 from Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages
25. Supplementary Figure 6 from Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages
26. Supplementary Figure 8 from Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages
27. Selective inhibition of HDAC6 regulates expression of the oncogenic driver EWSR1-FLI1 through the EWSR1 promoter in Ewing sarcoma
28. Contributors
29. Pathophysiology roles and translational opportunities of miRNAs in sarcomas
30. Characterization of the molecular mechanisms mediated by the insulin-like growth factor-2 mRNA-binding proteins and Ephrin receptor A2 (EPHA2) signaling in the malignancy of CIC-DUX4 sarcomas
31. Biology of Ewing Sarcoma
32. Targeting DNA Methylation Machinery in Pediatric Solid Tumors.
33. Lamin A and the LINC complex act as potential tumor suppressors in Ewing Sarcoma
34. Correction to: ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis
35. IL-1 Family Members in Bone Sarcomas
36. Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages
37. Single-nucleotide polymorphism profiling by multimodal-targeted next-generation sequencing in methotrexate-resistant and -sensitive human osteosarcoma cell lines
38. PROTAC-Based Protein Degradation as a Promising Strategy for Targeted Therapy in Sarcomas
39. Figure S2 from USP1 Expression Driven by EWS::FLI1 Transcription Factor Stabilizes Survivin and Mitigates Replication Stress in Ewing Sarcoma
40. Supplementary Data File S1 from USP1 Expression Driven by EWS::FLI1 Transcription Factor Stabilizes Survivin and Mitigates Replication Stress in Ewing Sarcoma
41. Data from USP1 Expression Driven by EWS::FLI1 Transcription Factor Stabilizes Survivin and Mitigates Replication Stress in Ewing Sarcoma
42. Therapeutic vulnerability to PARP1,2 inhibition in RB1-mutant osteosarcoma
43. Circulating miR34a levels as a potential biomarker in the follow-up of Ewing sarcoma
44. Ewing Sarcoma PDX Models
45. CD99 Modulates the Proteomic Landscape of Ewing Sarcoma Cells and Related Extracellular Vesicles.
46. Supplementary Data 3 from Endoglin, a Novel Biomarker and Therapeutical Target to Prevent Malignant Peripheral Nerve Sheath Tumor Growth and Metastasis
47. Supplementary Data 2 from Endoglin, a Novel Biomarker and Therapeutical Target to Prevent Malignant Peripheral Nerve Sheath Tumor Growth and Metastasis
48. Suppl. Figure 6 from Endoglin, a Novel Biomarker and Therapeutical Target to Prevent Malignant Peripheral Nerve Sheath Tumor Growth and Metastasis
49. Suppl. Figure 5 from Endoglin, a Novel Biomarker and Therapeutical Target to Prevent Malignant Peripheral Nerve Sheath Tumor Growth and Metastasis
50. Suppl. Figure 1 from Endoglin, a Novel Biomarker and Therapeutical Target to Prevent Malignant Peripheral Nerve Sheath Tumor Growth and Metastasis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.